Hemangiosarcoma

There were many studies, articles and books Dr. Dressler and Dr. Ettinger used when writing The Dog Cancer Survival Guide. Here is a list of the most important references about hemangiosarcoma in dogs.

Please note that in vivo and clinical use citations were included whenever possible. We have also included links to the papers, where available. Most of the papers are found on the National Institute of Health’s online library, PubMed.

Johnson KD Splenic Tumors, in Henry CJ, Higginbotham ML (ed): Cancer Management in Small Animal Practice. Missouri. Saunders Elsevier 2010, p 264-68.

Tumors of the Skin, Subcutis and other soft tissues. Northrup N, Geiger T, in Henry CJ, Higginbotham ML (ed): Cancer Management in Small Animal Practice. Missouri. Saunders Elsevier 2010, p 299.

Hemangiosarcoma. Chun R, in Cote E (2nd ed), Clinical Veterinary Advisor: Dogs and Cats. Missouri, Mosby Elsevier, 2011, p 482-486.

Hemangiosarcoma, Cardiac. Edwards NJ, in Cote E (ed), Clinical Veterinary Advisor: Dogs and Cats. Missouri, Mosby Elsevier, 2007, p 473-75.

Miscellaneous Tumors. Thamm DH, in Withrow SJ, Vail DM (eds): Withrow & MacEwen’s Small Animal Clinical Oncology. Missouri, Saunders Elsevier, 2007, pp 785-823.

Hemangiosarcoma in dogs and cats. Smith A. Vet Clin Small Anim 33:533-552, 2003.

Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985-1989), Spangler WL, Culbertson MR. J Am Vet Med Assoc 200:829, 1992.

Treatment of canine hemangiosarcoma: 2000 and beyond. Clifford CA, Mackin AJ, Henry CJ. J Vet Intern Med 14:479, 2000.

Magnetic resonance imaging of focal splenic and hepatic lesions in the dog. Clifford CA, Pretorius ES, Weisse C et al. J Vet Intern Med. 18(3):330-8. 2004\

Vascular endothelial growth factor concentrations in body cavity effusions in dogs. Clifford CA, Hughes D, Beal MW, et al. J Vet Intern Med. 16(2):164-8. 2002

Ventricular arrhythmias in dogs with splenic masses. Keyes M, Rush J. Vet Emerg Crit Care 3:33-38. 1994

Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Vail DM, MacEwen EG, Kurzman ID, et al. Clin Cancer Res 81:935, 1995.

Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs. Lana S, U’ren L, Plaza S, et al. J Vet Intern Med 21:764, 2007.

Splenomegaly in dogs. Predictors of neoplasia and survival after splenectomy. Johnson KA, Powers BE, Withrow SJ, et al. J Vet Intern Med 3:160, 1989.

Pathologic factors affecting postsplenectomy survival in dogs. Spangler WL, Kass PH. J Vet Intern Med 11:166, 1997

Metastatic pattern in dogs with splenic hemangiosarcoma. Waters D, Hayden D, Walter P. J Small Anim Pract 3:222, 1988.

Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma. Sorenmo KU, Beaz JL, Clifford CA, et al. J Vet Intern Med 18:209-213, 2004

Canine hemangiosarcoma treated with standard chemotherapy and minocycline. Sorenmo K, Duda L, Barber L, et al. J Vet Intern Med. 14(4): 395-8. 2000

Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis, sarcomatosis, and mesothelioma, with or without malignant effusions: a retrospective analysis of 12 cases (1997-2002). Charney SC, Bergman PJ, McKnight JA, et al. Vet Comp Oncol 3:171, 2005.